
| Dosaggio del prodotto: 25 mg | |||
|---|---|---|---|
| Confezione (n.) | Per tablet | Prezzo | Acquista |
| 60 | €0.68 | €40.99 (0%) | 🛒 Aggiungi al carrello |
| 90 | €0.47 | €61.49 €42.70 (31%) | 🛒 Aggiungi al carrello |
| 120 | €0.38 | €81.98 €46.11 (44%) | 🛒 Aggiungi al carrello |
| 180 | €0.32 | €122.97 €58.07 (53%) | 🛒 Aggiungi al carrello |
| 270 | €0.26
Migliore per tablet | €184.46 €69.17 (62%) | 🛒 Aggiungi al carrello |
Sinonimi | |||
More info:
Popular Products
Micardis Plus: Эффективный контроль артериальной гипертензии при фиксированной комбинации - Обзор на основе доказательств
Product Description: Micardis Plus представляет собой комбинированный антигипертензивный препарат, содержащий два активных компонента с взаимодополняющим механизмом действия: телмисартан (антагонист рецепторов ангиотензина II, или БРА) и гидрохлоротиазид (тиазидный диуретик). Эта фиксированная комбинация предназначена для лечения эссенциальной артериальной гипертензии у пациентов, у которых монотерапия телмисартаном не обеспечивает адекватного контроля артериального давления. Препарат выпускается в таблетированной форме с различными дозировками (например, телмисартан 40 мг + гидрохлоротиазид 12,5 мг; телмисартан 80 мг + гидрохлоротиазид 12,5 мг).
Ashwagandha: Clinically-Supported Stress Adaptation and Neuroendocrine Balance - Evidence-Based Review
Product Description Ashwagandha, known scientifically as Withania somnifera, is a cornerstone botanical of Ayurvedic medicine, traditionally classified as a “rasayana” or rejuvenating herb. In modern clinical practice and supplement use, it is primarily recognized as a potent adaptogen. This means it helps the body modulate its physiological and neuroendocrine response to stress, promoting a state of homeostasis. The therapeutic activity is largely attributed to a concentrated group of bioactive steroidal lactones called withanolides, with withaferin A and withanolide D being among the most studied.
Isoniazid
Isoniazid: A cornerstone prophylactic and therapeutic agent for tuberculosis. This comprehensive monograph details its mechanism of action, clinical efficacy, dosing regimens, and critical safety profile. Learn about the evidence base, management of hepatotoxicity, and its role in modern TB control strategies from a clinical perspective. Let’s talk about Isoniazid. If you’re in the trenches of public health, infectious disease, or even primary care in a high-burden area, this isn’t just another drug on the shelf.
Nexium
Nexium (esomeprazole) est un inhibiteur de la pompe à protons (IPP) de prescription utilisé pour traiter les troubles liés à l’acide gastrique. Ce monographie détaille son mécanisme d’action, ses indications cliniques validées, sa posologie et son profil sécurité. Apprenez les preuves scientifiques derrière son efficacité et son utilisation en pratique courante. 1. Introduction: Qu’est-ce que Nexium? Son Rôle en Médecine Moderne Nexium, dont le principe actif est l’ésoméprazole, est un médicament appartenant à la classe thérapeutique des inhibiteurs de la pompe à protons (IPP).
Super P Force Oral Jelly: Terapia Combinata per DE ed EP - Monografia Evidenze-Based
Product Description: Super P Force Oral Jelly è una formulazione farmacologica combinata, presentata in una forma orale gelatinosa (jelly), destinata al trattamento simultaneo di due condizioni maschili: la disfunzione erettile (DE) e l’eiaculazione precoce (EP). Il prodotto unisce due principi attivi ben noti: il sildenafil citrato, un inibitore della fosfodiesterasi di tipo 5 (PDE5), e la dapoxetina cloridrato, un inibitore selettivo della ricaptazione della serotonina (SSRI) a breve durata d’azione. La forma in gel, spesso aromatizzata, è stata sviluppata per offrire un’alternativa a più rapida assorbimento e potenzialmente più facile da assumere rispetto alle tradizionali compresse rivestite, particolarmente per pazienti con disfagia o preferenze personali.
Dapsone
Let me tell you about dapsone. It’s one of those agents that sits in the therapeutic toolbox, not first-line for most things, but absolutely irreplaceable for a few. It’s a sulfone antibiotic, structurally related to the sulfonamides, but its utility in modern dermatology and beyond is largely tied to its unique anti-inflammatory effects, not its antimicrobial ones. I remember first encountering it in residency, buried in the formulary, mostly discussed in hushed tones because of its hematologic risks.
Budecort Inhaler
Budecort Inhaler: A comprehensive guide to the inhaled corticosteroid budesonide. Learn about its mechanism of action for controlling airway inflammation in asthma and COPD, proper dosing, and evidence-based clinical applications. Understand the safety profile, contraindications, and how it compares to other therapies. Learn about the mechanism of action and clinical evidence. Product Description The Budecort Inhaler is a metered-dose inhaler (MDI) containing the corticosteroid budesonide as its active pharmaceutical ingredient.
Tadalista: Effective Treatment for Erectile Dysfunction and BPH - Evidence-Based Review
Product Description: Tadalista is a pharmaceutical product containing the active substance Tadalafil, a potent and selective inhibitor of phosphodiesterase type 5 (PDE5). It is indicated for the treatment of erectile dysfunction (ED) in adult men. Tadalafil works by enhancing blood flow to the penile tissue during sexual stimulation, facilitating the achievement and maintenance of an erection. It is also approved for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of both ED and BPH when the conditions coexist.
Brafix Cranial Orthosis: Evidence-Based Correction for Positional Plagiocephaly
Product Description: Brafix is a Class IIa medical device, specifically a non-invasive cranial remolding orthosis, designed for the management of positional plagiocephaly, brachycephaly, and scaphocephaly in infants. It functions through the application of gentle, persistent pressure to guide cranial growth during a period of rapid development, promoting symmetrical skull formation. Its use is indicated when conservative repositioning therapy has proven insufficient, typically for infants aged 3 to 18 months with moderate to severe cranial deformation.














